Prospective Evaluation of 14F Thal Tube vs 28 French Chest Tube for Hemothorax and Use of Maximum Barrier Precautions
2 other identifiers
interventional
193
1 country
1
Brief Summary
Traumatic hemothorax and hemopneumothorax are common diagnoses which are typically treated by placement of a chest tube. 28-32 Fr chest tubes have previously been shown equivalent to 36-40 Fr chest tubes for the non-emergent drainage of hemothorax. A smaller study has found 14 Fr pigtails had less pain than larger tubes but was not powered to compare outcomes. We seek to perform a prospective randomized trial that is adequately powered comparing efficacy of 14 Fr thal tubes to 28 Fr chest tubes for non-emergent drainage of hemothorax and hemopneumothorax. Additionally, we will employ maximal barrier precautions for all chest tube insertions and compare empyema rates to our historical controls.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 8, 2017
CompletedFirst Submitted
Initial submission to the registry
May 24, 2017
CompletedFirst Posted
Study publicly available on registry
May 30, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2021
CompletedResults Posted
Study results publicly available
March 29, 2023
CompletedMarch 29, 2023
August 1, 2022
4.6 years
May 24, 2017
November 30, 2022
March 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants With Retained Hemothorax Following Initial Chest Tube Placement Requiring Intervention
Number of Participants with Retained hemothorax requiring an additional intervention, either video-assisted thoracoscopic surgery (VATS) or additional thoracostomy tube placement.
90 days
Secondary Outcomes (9)
Duration of Chest Tube Placement.
90 days
Number of Participants Stratified by Length of Hospitalization Stay
90 days
Change in Subjective Pain Scores From Baseline at 90 Days
90 days
Hemodynamic Stability Post-insertion
90 days
Initial Drainage From Chest Tube at 5 Minutes
5 Minutes
- +4 more secondary outcomes
Study Arms (2)
28 French chest tube for hemothorax
EXPERIMENTAL28 French straight chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax
14 French chest tube for hemothorax
EXPERIMENTAL14 French thal chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax
Interventions
Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
Eligibility Criteria
You may qualify if:
- The patient is admitted to the trauma service.
- The patient has a hemothorax and/or or hemopneumothorax, requiring thoracostomy tube placement.
- Thoracostomy tube placement is able to be performed or witnessed by an investigator listed on the study.
- The patient has not had a chest tube in the past year.
- The patient is \>18 years of age.
- In the event the patient is decisionally impaired, consent will be obtained from the individual's legally authorized representative (LAR) or from the individual's healthcare power of attorney (HPA).
- In the instance of reversible impairment, initial consent would be obtained from the LAR/HPA and the patient will be approached for consent once he/she is deemed mentally competent by the care provider.
You may not qualify if:
- The patient is incarcerated
- The patient is known to be pregnant
- The patient is \< 18 years of age
- The patient is hemodynamically unstable, requiring emergent chest tube placement (in \<10 minutes from evaluation).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Carolinas Medical Center
Charlotte, North Carolina, 28203, United States
Related Publications (4)
Karmy-Jones R, Holevar M, Sullivan RJ, Fleisig A, Jurkovich GJ. Residual hemothorax after chest tube placement correlates with increased risk of empyema following traumatic injury. Can Respir J. 2008 Jul-Aug;15(5):255-8. doi: 10.1155/2008/918951.
PMID: 18716687BACKGROUNDInaba K, Lustenberger T, Recinos G, Georgiou C, Velmahos GC, Brown C, Salim A, Demetriades D, Rhee P. Does size matter? A prospective analysis of 28-32 versus 36-40 French chest tube size in trauma. J Trauma Acute Care Surg. 2012 Feb;72(2):422-7. doi: 10.1097/TA.0b013e3182452444.
PMID: 22327984RESULTKulvatunyou N, Erickson L, Vijayasekaran A, Gries L, Joseph B, Friese RF, O'Keeffe T, Tang AL, Wynne JL, Rhee P. Randomized clinical trial of pigtail catheter versus chest tube in injured patients with uncomplicated traumatic pneumothorax. Br J Surg. 2014 Jan;101(2):17-22. doi: 10.1002/bjs.9377.
PMID: 24375295RESULTMcCartt J, Ross SW, Cunningham KW, Wang H, Sealey L, Brake J, Christmas A, Sachdev G, Green J, Thomas BW. A Randomized Non-Inferiority Clinical Trial of 14Fr Thal versus 28Fr Tube Thoracostomy for Traumatic Hemothorax. Am Surg. 2025 Apr;91(4):579-586. doi: 10.1177/00031348241308907. Epub 2024 Dec 19.
PMID: 39700058DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Bradley Thomas MD
- Organization
- Atrium Health Wake Forest
Study Officials
- PRINCIPAL INVESTIGATOR
Bradley W Thomas, MD
Wake Forest University Health Sciences
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- Investigator masked to outcomes data.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 24, 2017
First Posted
May 30, 2017
Study Start
May 8, 2017
Primary Completion
December 20, 2021
Study Completion
December 20, 2021
Last Updated
March 29, 2023
Results First Posted
March 29, 2023
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share